Erratum to New mouse models for metabolic bone diseases generated by genome-wide ENU mutagenesis (Mamm Genome, (2012), 23, (416-430), 10.1007/s00335-012-9397-z);New mouse models for metabolic bone diseases generated by genome-wide ENU mutagenesis

Mammalian Genome

Volumn 23, Issue 7-8, 2012, Pages 416-430

  Sabrautzki, Sibylle ^a   Rubio Aliaga, Isabel ^a   Hans, Wolfgang ^a   Fuchs, Helmut ^a   Rathkolb, Birgit ^b   Calzada Wack, Julia ^a   Cohrs, Christian M ^a   Klaften, Matthias ^a,e   Seedorf, Hartwig ^c   Eck, Sebastian ^a   Benet Pagès, Ana ^a   Favor, Jack ^a   Esposito, Irene ^a,d   Strom, Tim M ^a   Wolf, Eckhard ^b   Lorenz Depiereux, Bettina ^a   Hrabě De Angelis, Martin ^a,d  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; CALCIUM; PHOSPHATE;

ALKALINE PHOSPHATASE BLOOD LEVEL; ALKALINE PHOSPHATASE LIVER BONE KIDNEY GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASGR1 GENE; BONE TURNOVER; CALCIUM BLOOD LEVEL; CALCIUM SENSING RECEPTOR GENE; CONTROLLED STUDY; DISEASE MODEL; FEMALE; GENE MUTATION; MALE; METABOLIC BONE DISEASE; MOUSE; MUTAGENESIS; MUTATIONAL ANALYSIS; N ETHYL N NITROSOUREA MUTAGENESIS; NONHUMAN; PHOSPHATE BLOOD LEVEL; PHOSPHATE REGULATING GENE WITH HOMOLOGIES TO ENDOPEPTIDASES ON THE X CHROMOSOME GENE; POINT MUTATION; SEQUENCE ANALYSIS;

ANIMALIA; MUS;

EID: 84865107729     PISSN: 09388990     EISSN: 14321777     Source Type: Journal    
DOI: 10.1007/s00335-014-9534-y     Document Type: Erratum

References (108)

1. Abe K, Fuchs H, Lisse T, Hans W, de Angelis Hrabě (2006) New ENU-induced semidominant mutation, Ali18, causes inflammatory arthritis, dermatitis, and osteoporosis in the mouse. Mamm Genome 17:915-926 (Pubitemid 44440395)
2. Abe K, Wechs S, Kalaydjiev S, Franz T, Busch DH (2007) Novel lymphocyte-independent mechanisms to initiate inflammatory arthritis via bone marrow derived cells of Ali18 mutant mice. Rheumatology 47(3):292-300 (Pubitemid 351267194)
3. Addison WN, Masica DL, Gray JJ, McKee MD (2010) Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage. J Bone Miner Res 25(4):695-705
4. ADHR Consortium (2000) Autosomal dominant hypophosphatemic rickets is associated with mutations in FGF23. Nat Genet 26(3):345-348
5. Aigner B, Rathkolb B, Mohr M, Klempt M, Hrabě de Angelis M et al (2007) Generation of ENU-induced mouse mutants with hypocholesterolemia: novel tools for dissecting plasma lipoprotein homeostasis. Lipids 42(8):731-737 (Pubitemid 47328758)
6. Aigner B, Rathkolb B, Klaften M, Sedlmeier R, Klempt M et al (2009) Generation of N-ethyl-N-nitrosourea-induced mouse mutants with deviations in plasma enzyme activities as novel organ-specific disease models. Exp Physiol 94(4):412-421
7. Aigner B, Rathkolb B, Klempt M, Wagner S, Michel D et al (2011) Generation of N-ethyl-N-nitrosourea-induced mouse mutants with deviations in hematological parameters. Mamm Genome 22:495-505
8. Ashwell G, Morell AG (1974) The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol Relat Areas Mol Biol 41:99-128
9. Avbersek-Luznik I, Gmeiner-Stopar T, Marc J (2007) Activity or mass concentration of bone-specific alkaline phosphatase as a marker of bone formation. Clin Chem Lab Med 45(8):1014-1018 (Pubitemid 47424851)
10. Badadani M, Nalbandian A, Watts GD, Vesa J, Kitazawa M (2010) VCP associated inclusion body myopathy and Paget disease of bone knock-in mouse model exhibits tissue pathology typical of human disease. PLoS One 5(10):e13183
11. Barbaric I, Perry MJ, Dear TN, Rodrigues Da Costa A, Salopek D (2008) An ENU-induced mutation in the Ankrd11 gene results in an osteopenia-like phenotype in the mouse mutant Yoda. Physiol Genomics 32(3):311-321 (Pubitemid 351328554)
12. Beck L, Karaplis AC, Amizuka N, Hewson AS, Ozawa H (1998) Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci USA 95(9):5372-5377 (Pubitemid 28208605)
13. Beck C, Morbach H, Richl P, Stenzel M, Girschick HJ (2009) How can calcium pyrophosphate crystals induce inflammation in hypophosphatasia or chronic inflammatory joint diseases? Rheumatol Int 29(3):229-238
14. Bergwitz C, Jüppner H (2010) Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med 61:91-104
15. Bilezikian JP, Brandi ML, Rubin M, Silverberg SJ (2005) Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features. J Int Med 257(1):6-17 (Pubitemid 40129122)
16. Bonadio J, Saunders TL, Tsai E, Goldstein SA, Morris-Winmann J et al (1990) Transgenic mouse model of the mild dominant form of osteogenesis imperfecta. Proc Natl Acad Sci USA 87:7145-7149
17. Braga V, Gatti D, Rossini M, Colapietro F, Battaglia E (2004) Bone turnover markers in patients with osteogenesis imperfecta. Bone 34(6):1013-1016 (Pubitemid 38749238)
18. +)-sensing receptor from bovine parathyroid. Nature 366:575-580 (Pubitemid 24035999)
19. Brownstein CA, Zhang J, Stillman A, Elis B, Troiano N et al (2010) Increased bone volume and correction of Hyp mouse hypophosphatemia in the Klotho/Hyp mouse. Endocrinology 151(2):492-501
20. Burnett CH, Dent CE, Harper C, Warland BJ (1964) Vitamin D-resistant rickets. Am J Med 36:222-232
21. Carpinelli MR, Wicks IP, Sims NA, O'Donnell K, Hanzinikolas K et al (2002) An ethyl-nitrosourea-induced point mutation in Phex causes exon skipping, X-linked hypophosphatemia, and rickets. Am J Pathol 161(5):1925-1933 (Pubitemid 35265549)
22. Chang W, Tu C, Chen TH, Bikle D, Shoback D (2008) The extracellular calcium-sensing receptor (CaDR) is a critical modulator of skeletal development. Sci Signal 1(35):ra1
23. Chavassieux P, Seeman E, Delmas PD (2007) Insights into material and structural basis of bone fragility from diseases associated with fractures: how determinants of the biomechanical properties of bone are compromised by disease. Endocr Rev 28:151-164 (Pubitemid 46984832)
24. Chipman SD, Sweet HO, McBride DJ Jr, Davisson MT, Marks SC Jr (1993) Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. Proc Natl Acad Sci USA 90(5):1701-1705 (Pubitemid 23069924)
25. Chodirker BN, Evans JA, Seargeant LE, Cheang MS, Greenberg CR (1990) Hyperphosphatemia in infantile hypophosphatasia: implications for carrier diagnosis and screening. Am J Hum Genet 46:280-285
26. Cundy T, Horne A, Bolland M, Gamble G, Davidson J (2007) Bone formation markers in adults with mild osteogenesis imperfecta. Clin Chem 53(6):1109-1114 (Pubitemid 46867528)
27. D'Souza-Li, Yang B, Canaff L, Bai M, Hanley DA et al (2002) Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia. J Clin Endocrinol Metab 87:1309-1318 (Pubitemid 36121103)
28. Daroszewska A, van' t Hof RJ, Rojas JA, Layfield R, Landao-Basonga E et al (2011) A point mutation in the ubiquitin associated domain of SQSMT1 is sufficient to cause a Paget's disease like disorder in mice. Hum Mol Genet 20(14):2734-2744
29. Delmas PD (1992) Clinical use of biochemical markers of bone remodeling in osteoporosis. Bone 13(Suppl 1):S17-S21
30. Du L, Desbarats M, Viel J, Glorieux FH, Cawthorn C et al (1996) cDNA cloning of the murine Phex gene implicated in X-linked hypophosphatemia and evidence for expression in bone. Genomics 36:22-28 (Pubitemid 26277754)
31. Ducy P, Desbois C, Boyce B, Pinero G, Story B et al (1996) Increased bone formation in osteocalcin-deficient mice. Nature 382(6590):448-452 (Pubitemid 26264860)
32. Eck SH, Benet-Pagès A, Flisikowski K, Meitinger T, Fries R et al (2009) Whole genome sequencing of a single Bos taurus animal for single nucleotide polymorphism discovery. Genome Biol 10(8):R82
33. Econs MJ, McEnery PT (1997) Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder. J Clin Endocrinol Metab 82(2):674-681 (Pubitemid 27068650)
34. Eicher EM, Southard JL (1972) Hypophosphatemia (Hyp); Chr 7 linkage. Mouse News Lett 47:36
35. Eicher EM, Southard JL, Scriver CR, Glorieux FH (1976) Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets. Proc Natl Acad Sci USA 73:4667-4671 (Pubitemid 8013582)
36. Farrow EG, Yu X, Summers LJ, Davis SI, Fleet JC et al (2011) Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice. Proc Natl Acad Sci USA 108(46):E1146-E1155
37. Feng JQ, Huang H, Lu Y, Ye L, Xie Y et al (2003) The Dentin matrix protein 1 (Dmp1) is specifically expressed in mineralized, but not soft, tissues during development. J Dent Res 82(10):776-780 (Pubitemid 41766106)
38. Feng JQ, Scott G, Guo D, Jiang B, Harris M et al (2008) Generation of a conditional null allele for Dmp1 in mouse. Genesis 46(2):87-91 (Pubitemid 351498178)
39. Ferron M, Wei J, Yoshizawa T, Del Fattore A, DePinho RA et al (2010) Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 142(2):296-308
40. Filisetti D, Ostermann G, von Bredow M, Strom T, Filler G et al (1999) Non-random distribution of mutations in the PHEX gene, and under-detected missense mutations at non-conserved residues. Eur J Hum Genet 7(5):615-619 (Pubitemid 29378040)
41. Forlino A, Porter FD, Lee EJ, Westphal H, Marini JC (1999) Use of the Cre/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an α1(I)G349C substitution. J Biol Chem 274(53):37923-37931 (Pubitemid 30026860)
42. Freeman DA (1988) Paget's disease of bone. Am J Med Sci 295(2):144-158
43. Fuchs H, Lisse T, Abe K, Hrabě de Angelis M (2006) Screening for bone and cartilage phenotypes in mice. In: Hrabě de Angelis M, Chambon P, Brown S (eds) Phenotyping of the laboratory mouse. Wiley-VCH, Weinheim, pp 35-86
44. Fuchs H, Gailus-Durner V, Adler T, Aguilar-Pimentel A, Becker L et al (2011) Mouse phenotyping. Methods 53(2):120-135
45. Fulzele K, Riddle RC, DiGirolamo D, Cao X, Wan C et al (2010) Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 142(2):309-319
46. Gailus-Durner V, Fuchs H, Becker L, Bolle I, Brielmeier M et al (2005) Introducing the German mouse clinic: open access platform for standardized phenotyping. Nat Methods 2(6):403-404 (Pubitemid 40916545)
47. Goseki-Sone M, Sogabe N, Fukushi-Irie M, Mizoi L, Orimo H et al (2005) Functional analysis of the single nucleotide polymorphism (787T > C) in the tissue-nonspecific alkaline phosphatase gene associated with BMD. J Bone Miner Res 20(5):773-782 (Pubitemid 40571634)
48. Ho C, Conner DA, Pollak MR, Ladd DJ, Kifor O et al (1995) A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet 11(4):389-394
49. Hough TA, Bogani D, Cheeseman MT, Favor J, Nesbit MA et al (2004) Activating calcium-sensing receptor mutation in the mouse is associated with cataracts and ectopic calcification. Proc Natl Acad Sci USA 101(37):13566-13571 (Pubitemid 39238443)
50. Hough TA, Polewski M, Johnson K, Cheeseman M, Nolan PM et al (2007) Novel mouse model of autosomal semidominant adult hypophosphatasia has a splice site mutation in the tissue nonspecific alkaline phosphatase gene akp2. J Bone Miner Res 22(9):1397-1407 (Pubitemid 351339684)
51. Hrabě de Angelis M, Balling R (1998) Lange scale ENU screens in the mouse: genetics meets genomics. Mutat Res 400(1-2):25-32 (Pubitemid 28440208)
52. Hrabě de Angelis M, Flaswinkel H, Fuchs H, Rathkolb B, Soewarto D et al (2000) Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat Genet 25(4):444-447 (Pubitemid 32983440)
53. HYP Consortium (1995) A gene (PHEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet 11(2):130-136
54. Imanishi Y, Hosokawa Y, Yoshimoto K, Schipani E, Mallya S et al (2001) Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. J Clin Invest 107(9):1093-1102 (Pubitemid 32422906)
55. Imel EA, Hui SL, Econs MJ (2007) FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets. J Bone Miner Res 22(4):520-526 (Pubitemid 47457428)
56. +)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Am J Hum Genet 56(4):880-886
57. Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T et al (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348(17):1656-1663 (Pubitemid 36459471)
58. Kato M, Patel MS, Levasseur R, Lobov I, Chang BH et al (2002) Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 157(2):303-314 (Pubitemid 34839826)
59. Klaften M, Hrabě de Angelis M (2005) ARTS: a web-based tool for the set-up of high-throughput genome-wide mapping panels for the SNP genotyping of mouse mutants. Nucleic Acids Res 33(Web Server Issue):W496-W500 (Pubitemid 44529970)
60. Klempt M, Rathkolb B, Fuchs H, Hrabé de Angelis M, Wolf E (2006) Genotype-specific environmental impact on the variance of blood values in inbred and F1 hybrid mice. Mamm Genome 17(2):93-102 (Pubitemid 43209148)
61. Kruse K, Woelfel D, Strom TM (2001) Loss of renal phosphate wasting in a child with autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation. Horm Res 55(6):305-308 (Pubitemid 34114179)
62. Kurima K, Peters LM, Yang Y, Riazuddin S, Ahmed ZM et al (2002) Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function. Nat Genet 30:277-284
63. Langston AL, Ralston SH (2004) Management of Paget's disease of bone. Rheumatology 43(8):955-959 (Pubitemid 39144439)
64. Lisse TS, Thiele F, Fuchs H, Hans W, Przemeck GK et al (2008) ER stress-mediated apoptosis in a new mouse model for osteogenesis imperfecta. PLoS Genet 4(2):e7 (Pubitemid 351328547)
65. Liu X (1995) A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling. J Cell Biol 130(1):227-237
66. Lomeli H, Ramos-Mejia V, Gertsenstein M, Lobe CG, Nagy A (2000) Targeted insertion of Cre recombinase into the TNAP gene: excision in primordial germ cells. Genesis 26(2):116-117 (Pubitemid 30158092)
67. Lorenz-Depiereux B, Guido VE, Johnson KR, Zheng QY, Gagnon LH et al (2004) New intragenic deletions in the Phex gene clarify X-linked hypophosphatemia-related abnormalities in mice. Mamm Genome 15(3):151-161 (Pubitemid 38293807)
68. Lorenz-Depiereux B, Bastepe M, Benet-Pagès A, Amyere M, Wagenstaller J et al (2006a) DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat Genet 38(11):1248-1250 (Pubitemid 44646286)
69. Lorenz-Depiereux B, Benet-Pagès A, Eckstein G, Tenenbaum-Rakover Y, Wagenstaller J et al (2006b) Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. Am J Hum Genet 78(2):193-201 (Pubitemid 43157560)
70. Lorenz-Depiereux B, Schnabel D, Tiosano D, Häusler G, Strom TM (2010) Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets. Am J Hum Genet 86(2):267-272
71. MacGregor GR, Zambrowicz BP, Soriano P (1995) Tissue non-specific alkaline phosphatase is expressed in both embryonic and extraembryonic lineages during mouse embryogenesis but is not required for migration of primordial germ cells. Development 121(5):1487-1496
72. Mäkitie O, Doria A, Kooh SW, Cole WG, Daneman A et al (2003) Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 88(8):3591-3597 (Pubitemid 37034500)
73. Marini JC, Cabral WA, Barnes AM (2010) Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfect. Cell Tissue Res 339(1):59-70
74. Marklund U, Hansson E, Sundström E, Hrabě de Angelis M, Przemeck GKH et al (2010) Domain-specific control of neurogenesis achieved through patterned regulation of notch ligand expression. Development 137:437-445
75. Marks SC Jr, Lane PW (1976) Osteopetrosis, a new recessive skeletal mutation on chromosome 12 of the mouse. J Hered 67:11-18
76. Marx SJ, Attie MF, Levine MA, Spiegel AM, Downs RW Jr et al (1981) The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine 60(6):397-412 (Pubitemid 12207234)
77. McGowan KA, Li JZ, Park CY, Beaudry V, Tabor HK et al (2008) Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat Genet 40(8):963-970
78. Mejia-Gaviria N, Gil-Peña H, Coto E, Pérez-Menéndez TM, Santos F (2010) Genetic and clinical peculiarities in a new family with hereditary hypophosphatemic rickets with hypercalciuria: a case report. Orphanet J Rare Des 5:1-4
79. Moriyama K, Hanai A, Mekada K, Yoshiki A, Ogiwara K et al (2011) Kbus/Idr, a mutant mouse strain with skeletal abnormalities and hypophosphatemia: identification as an allele of 'Hyp'. J Biomed Sci 18:60
80. Mornet E, Stura E, Lia-Baldini AS, Stigbrand T, Ménez A et al (2001) Structural evidence for a functional role of human tissue nonspecific alkaline phosphatase in bone mineralization. J Biol Chem 276(33):31171-31178
81. Moss DW (1994) Release of membrane-bound enzymes from cells and the generation of isoforms. Clin Chim Acta 226:131-142 (Pubitemid 24190200)
82. Nakajima K, Yamazaki K, Kimura H, Takano K, Miyoshi H et al (2009) Novel gain of function mutations of the calcium-sensing receptor in two patients with PTH-deficient hypocalcemia. Intern Med 48(22):1951-1956
83. Narisawa S, Fröhlander N, Millan JL (1997) Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia. Dev Dyn 208(3):432-446 (Pubitemid 27114295)
84. Nicklas W, Baneux P, Boot R, Decelle T, Deeny AA et al (2002) Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units. Lab Anim 36(1):20-42 (Pubitemid 34073119)
85. Panteghini M (1991) Benign inherited hyperphosphatemia of intestinal origin: report of two cases and a brief review of the literature. Clin Chem 37(8):1449-1452 (Pubitemid 21925989)
86. Pedrazzoni M, Alfano FS, Girasole G, Giuliani N, Fantuzzi M et al (1996) Clinical observations with a new specific assay for bone alkaline phosphatase: a cross-sectional study in osteoporotic and pagetic subjects and a longitudinal evaluation of the response to ovariectomy, estrogens, and bisphosphonates. Calcif Tissue Int 59(5):334-338 (Pubitemid 26367079)
87. 2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75:1297-1303 (Pubitemid 24021905)
88. Pollak MR, Chou YHW, Marx SJ, Steinmann B, Cole DEC et al (1994) Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. J Clin Invest 93(3):1108-1112
89. Rathkolb B, Decker T, Fuchs E, Soewarto D, Fella C et al (2000) The clinical-chemical screen in the Munich ENU mouse mutagenesis project: screening for clinically relevant phenotypes. Mamm Genome 11:543-546 (Pubitemid 30602221)
90. Rauch DA, Hurchla MA, Harding JC, Deng H, Shea LK et al (2010) The ARF tumor suppressor regulates bone remodeling and osteosarcoma development in mice. PLoS One 5(12):e15755
91. Rubio-Aliaga I, Soewarto D, Wagner S, Klaften M, Fuchs H et al (2007) A genetic screen for modifiers of the delta-1-dependent notch signaling function in the mouse. Genetics 175(3):1451-1463 (Pubitemid 46798244)
92. Segawa H, Onitsuka A, Kuwahata M, Hanabusa E, Furutani J et al (2009) Type IIc sodium-dependent phosphate transporter regulates calcium metabolism. J Am Soc Nephrol 20(1):104-113
93. Simon-Bouy B, Taillandier A, Fauvert D, Brun-Heath I, Serre JL et al (2008) Hypophosphatasia: molecular testing of 19 prenatal cases and discussion about genetic counseling. Prenat Diagn 28(11):993-998 (Pubitemid 352789463)
94. Singer FR, Clemens TL, Eusebio RA, Bekker PJ (1998) Risedronate, a highly effective oral agent in the treatment of patients with severe Paget's disease. J Clin Endocrinol Metab 83(6):1906-1910 (Pubitemid 28496314)
95. Siraganian PA, Mulvihill JJ, Mulivor RA, Miller RW (1989) Benign familial hyperphosphatasemia. JAMA 261(9):1310-1312 (Pubitemid 19072224)
96. Smits P, Bolton AD, Funari VM, Hong M, Boyden ED et al (2010) Lethal skeletal dysplasia in mice and humans lacking the golgin GMAP-210. N Engl J Med 362:206-216
97. Soewarto D, Fella C, Teubner A, Rathkolb B, Pargent W et al (2000) The large-scale Munich ENU-mouse-mutagenesis screen. Mamm Genome 11(7):507-510 (Pubitemid 30602214)
98. Soewarto D, Klaften M, Rubio-Aliago I (2009) Features and strategies of ENU mouse mutagenesis. Curr Pharm Biotech 10:198-213
99. Srivastava AK, Bhattacharyya S, Li X, Mohan S, Baylink DJ (2001) Circadian and longitudinal variation of serum C-telopeptide, osteocalcin, and skeletal alkaline phosphatase in C3H/HeJ mice. Bone 29(4):361-367 (Pubitemid 32930063)
100. Srivastava AK, Mohan S, Wergedahl JE, Baylink DJ (2003) A genomewide screening of N-ethyl-N-nitrosourea-mutagenized mice for musculoskeletal phenotypes. Bone 33:179-191 (Pubitemid 37117130)
101. Strom TM, Jüppner H (2008) PHEX, FGF23, DMP1 and beyond. Curr Opin Nephrol Hypertens 17(4):357-362
102. Taillandier A, Cozien E, Muller F, Merrien F, Bonnin E et al (2000) Fifteen new mutations (-195C > T, L-12X, 298-2A > G, T117 N, A159T, R229S, 997+2T > A, E274X, A331T, H364R, D389G, 1256delC, R433H, N461I, C472S) in the tissue-nonspecific alkaline phosphatase (TNSALP) gene in patients with hypophosphatasia. Hum Mutat 15:292-293
103. Tenenhouse HS (1999) X-linked hypophosphataemia: a homologous disorder in humans and mice. Nephrol Dial Transpl 14:333-341 (Pubitemid 29062787)
104. Tieder M, Modai D, Samuel R, Arie R, Halabe A et al (1985) Hereditary hypophosphatemic rickets with hypercalciuria. N Engl J Med 312(10):611-617 (Pubitemid 15133676)
105. Tiosano D, Hochberg Z (2009) Hypophosphatemia: the common denominator of all rickets. J Bone Miner Metab 27(4):392-401
106. Wenkert D, McAlister WH, Coburn SP, Zerega JA, Ryan LM et al (2011) Hypophosphatasia: nonlethal disease despite skeletal presentation in utero (17 new cases and literature review). J Bone Miner Res 26(10):2389-2398
107. Whyte MP (2010) Physiological role of alkaline phosphatase explored in hypophosphatasia. Ann NY Acad Sci 1192(1):190-200
108. Xiong X, Qi X, Ge X, Gu P, Zhao J et al (2008) A novel Phex mutation with defective glycosylation causes hypophosphatemia and rickets in mice. J Biomed Sci 15(1):47-59 (Pubitemid 350215832)